Effectiveness of Different Methods in Acute Myofascial Pain Syndrome

Effectiveness of 3 Different Methods in Acute Myofascial Pain Syndrome: A Randomized Controlled Study

This study is a randomized controlled study. A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days were included in the study. Patients were randomly divided into 3 groups. Group 1 patients received kinesio tape method (25 patients), group 2 patients received trigger point injection method (25 patients), and group 3 patients received neural therapy injection method (25 patients). A 10-15 cm sized I band was applied to the trapezius muscles of the first group patients with the patient's neck in lateral flexion. Then, while the patient's neck is flexed, a Y-shaped 15-20 cm tape will be affixed between C1-7 with the arms of the Y up, and I tape of 5-10 cm is attached on the arms. In group 2 patients, 1 cc lidocaine diluted with 4 cc saline (SF) was applied to the trigger points palpated manually in the trapezius muscles. After the trigger point was squeezed between the thumb and index finger, a few cc of local anesthetic mixture was applied into the trigger point with the injector and exited. In the 3rd group patients, a few cc local anesthetic mixture will be applied intradermally over the trigger point without entering into the trigger points palpated manually in the trapezius muscles. Patients were checked 72 hours and 1 week after the first applications.

The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm). The number of trigger points was determined by the physician by hand palpation. Pressure pain threshold was evaluated with the algometer device. Disability assessment of the patients was made using the neck pain disability index. evaluations were made at the beginning of treatment, 72 hours after and 1 week after treatment.

Study Overview

• Status: Completed
• Conditions: Myofacial Pain Syndromes
• Intervention / Treatment: Other: Kinesio taping

• Study Type: Observational
• Enrollment (Actual): 75

Contacts and Locations

Study Locations

• Turkey
  • Ankara, Turkey
    • Ufuk University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

A total of 75 patients between the ages of 20-50 who have a diagnosis of acute myofacial pain syndrome in the trapezius muscle and have pain for a maximum of 5 days.

Description

Inclusion Criteria:

• Patients diagnosed with acute myofascial pain syndrome
• Patients between the ages of 20-50
• Patients with pain for up to 5 days

Exclusion Criteria:

• Patients diagnosed with fibromyalgia
• Patients with systemic disease
• Patients with prominent cervical disc herniation
• Patients with cervical arthrosis
• Patients with cervical radiculopathy and myelopathy
• Patients with myofascial trigger point injection in the past 6 months
• Patients who received physical therapy in the past 6 months
• Patients undergoing shoulder and neck surgery
• Patients with drug allergies

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Visual analog scale	The pain at rest and during movement of the patients in all 3 groups were evaluated with a visual analog scale (VAS 10 cm).	1 week
The number of trigger points	The number of trigger points was determined by the physician by hand palpation.	1 week
Pressure pain threshold	Pressure pain threshold was evaluated with the algometer device.	1 week
Neck pain disability index	Disability assessment of the patients was made using the neck pain disability index.	1 week

Collaborators and Investigators

• Sponsor: Ufuk University
• Investigators: Principal Investigator: saime ay, Ufuk University

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2017
• Primary Completion (Actual): April 1, 2019
• Study Completion (Actual): April 1, 2019

Study Registration Dates

• First Submitted: March 29, 2021
• First Submitted That Met QC Criteria: March 29, 2021
• First Posted (Actual): April 1, 2021

Study Record Updates

• Last Update Posted (Actual): April 1, 2021
• Last Update Submitted That Met QC Criteria: March 29, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Pathologic Processes; Nervous System Diseases; Pain; Neurologic Manifestations; Disease; Musculoskeletal Diseases; Rheumatic Diseases; Muscular Diseases; Neuromuscular Diseases; Stomatognathic Diseases; Mouth Diseases; Cranial Nerve Diseases; Facial Nerve Diseases; Syndrome; Fibromyalgia; Somatoform Disorders; Myofascial Pain Syndromes; Facial Neuralgia; Facial Pain
• Other Study ID Numbers: 29032017-8

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No